BRPI0411451A - formas de dosagens orais de memantina - Google Patents
formas de dosagens orais de memantinaInfo
- Publication number
- BRPI0411451A BRPI0411451A BRPI0411451-5A BRPI0411451A BRPI0411451A BR PI0411451 A BRPI0411451 A BR PI0411451A BR PI0411451 A BRPI0411451 A BR PI0411451A BR PI0411451 A BRPI0411451 A BR PI0411451A
- Authority
- BR
- Brazil
- Prior art keywords
- memantine
- dosage form
- oral dosage
- dosage forms
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"FORMAS DE DOSAGENS ORAIS DE MEMANTINA". A presente invenção refere-se a uma forma de dosagem oral contendo entre 1 mg e 100 mg de memantina, em que a forma de dosagem referida não contém 10 mg de memantina ou 20 mg de memantina, e em que a forma de dosagem referida não é preparada pelo paciente ou por uma pessoa que esteja administrando o fármaco ao paciente que divide a forma de dosagem contendo uma dose maior de memantina. Outro aspecto desta invenção refere-se a produtos farmacêuticos compreendendo as formas de dosagens referidas e métodos para administrar memantina e tratar doença com a forma de dosagem referida.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47897903P | 2003-06-16 | 2003-06-16 | |
| PCT/US2004/018506 WO2004112768A1 (en) | 2003-06-16 | 2004-06-10 | Memantine oral dosage forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0411451A true BRPI0411451A (pt) | 2006-07-18 |
Family
ID=33539133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0411451-5A BRPI0411451A (pt) | 2003-06-16 | 2004-06-10 | formas de dosagens orais de memantina |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20040254251A1 (pt) |
| EP (1) | EP1631273A1 (pt) |
| JP (1) | JP2006527774A (pt) |
| KR (1) | KR20060033727A (pt) |
| CN (1) | CN1805737A (pt) |
| AU (1) | AU2004249151A1 (pt) |
| BR (1) | BRPI0411451A (pt) |
| CA (1) | CA2529535A1 (pt) |
| IL (1) | IL172233A0 (pt) |
| MX (1) | MXPA05012810A (pt) |
| NO (1) | NO20055880L (pt) |
| PL (1) | PL378902A1 (pt) |
| RU (1) | RU2006101225A (pt) |
| TW (1) | TW200524639A (pt) |
| WO (1) | WO2004112768A1 (pt) |
| ZA (1) | ZA200509379B (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7086532B2 (en) * | 2003-07-16 | 2006-08-08 | Allergan, Inc. | Titration/compliance pack with increasing doses |
| FR2855344A1 (fr) * | 2003-05-22 | 2004-11-26 | France Telecom | Systeme de gestion de contexte pour un reseau comportant un ensemble heterogene de terminaux |
| US20060002999A1 (en) * | 2004-06-17 | 2006-01-05 | Forest Laboratories, Inc. | Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
| EP1765287A2 (en) * | 2004-06-17 | 2007-03-28 | Merz Pharma GmbH & Co. KGaA | Immediate release formulations of memantine oral dosage forms |
| EP1827385B1 (en) * | 2004-11-23 | 2013-03-27 | Adamas Pharmaceuticals, Inc. | Pharmaceutical composition comprising memantine in an extended dosage release form for use in the treatment of dementias |
| US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
| US8481565B2 (en) | 2004-12-27 | 2013-07-09 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
| US20060159753A1 (en) * | 2004-12-27 | 2006-07-20 | Eisai Co. Ltd. | Matrix type sustained-release preparation containing basic drug or salt thereof |
| US20060160852A1 (en) * | 2004-12-27 | 2006-07-20 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
| WO2006121560A2 (en) | 2005-04-06 | 2006-11-16 | Adamas Pharmaceuticals, Inc. | Methods and compositions for treatment of cns disorders |
| NZ562120A (en) * | 2005-04-28 | 2010-07-30 | Eisai R&D Man Co Ltd | Composition comprising donepezil and memantine as antidementia agents |
| US7674793B2 (en) * | 2006-02-10 | 2010-03-09 | Janssen Pharmaceutica Nv | Tricyclic dihydropyrazines as potassium channel openers |
| EP2017289A4 (en) * | 2006-04-20 | 2011-07-27 | Itoham Foods Inc | PHARMACEUTICAL COMPOSITION FOR CONFORMATIONAL DISEASE |
| US20080008752A1 (en) * | 2006-07-05 | 2008-01-10 | Julia Hrakovsky | Pharmaceutical compositions of memantine |
| EP1908748A1 (en) * | 2006-10-05 | 2008-04-09 | Krka | Process for the preparation of memantine and its hydrochloric acid salt form |
| MX2009004516A (es) * | 2006-10-27 | 2009-08-12 | Medivation Neurology Inc | Metodos y terapias de combinacion para tratar enfermedad de alzheimer. |
| US20080182908A1 (en) * | 2007-01-25 | 2008-07-31 | Vinita Umashankar Vyas | Pharmaceutical compositions comprising memantine |
| US20100292341A1 (en) * | 2007-06-29 | 2010-11-18 | Orchid Chemicals & Pharmaceuticals Limited | Quick dissolve compositions of memantine hydrochloride |
| EP2583669A1 (en) | 2007-10-10 | 2013-04-24 | Rubicon Research Private Limited | Taste-masked orally disintegrating tablets of memantine hydrochloride |
| WO2009091932A2 (en) * | 2008-01-18 | 2009-07-23 | Adamas Pharmaceuticals, Inc. | Treatment of mild dementia of the alzheimer's disease type |
| US20090247644A1 (en) * | 2008-03-28 | 2009-10-01 | Forest Laboratories Holdings Limited | Memantine formulations |
| BR112012013487A2 (pt) | 2009-12-02 | 2017-10-03 | Adamas Pharmaceuticals Inc | Composições de amantadina e métodos de uso |
| ES2694224T3 (es) * | 2012-04-24 | 2018-12-19 | Daiichi Sankyo Company, Limited | Comprimido de desintegración oral y procedimiento para producir el mismo |
| US10154971B2 (en) | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
| KR20190076711A (ko) | 2017-12-22 | 2019-07-02 | 한미약품 주식회사 | 메만틴을 포함하는 속방성 및 서방성을 동시에 가지는 경질캡슐 제제 및 그 제조방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2856393C2 (de) * | 1978-12-27 | 1983-04-28 | Merz + Co GmbH & Co, 6000 Frankfurt | Arzneimittel zur Behandlung von Morbus Parkinson |
| AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
| US6057373A (en) * | 1997-05-22 | 2000-05-02 | Synchroneuron, Llc | Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists |
| US6849271B2 (en) * | 2001-04-27 | 2005-02-01 | Verion, Inc. | Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods |
-
2004
- 2004-06-10 CA CA002529535A patent/CA2529535A1/en not_active Abandoned
- 2004-06-10 KR KR1020057024218A patent/KR20060033727A/ko not_active Application Discontinuation
- 2004-06-10 CN CNA2004800167729A patent/CN1805737A/zh active Pending
- 2004-06-10 MX MXPA05012810A patent/MXPA05012810A/es not_active Application Discontinuation
- 2004-06-10 EP EP04754939A patent/EP1631273A1/en not_active Withdrawn
- 2004-06-10 WO PCT/US2004/018506 patent/WO2004112768A1/en active Application Filing
- 2004-06-10 BR BRPI0411451-5A patent/BRPI0411451A/pt not_active IP Right Cessation
- 2004-06-10 PL PL378902A patent/PL378902A1/pl not_active Application Discontinuation
- 2004-06-10 JP JP2006517215A patent/JP2006527774A/ja active Pending
- 2004-06-10 RU RU2006101225/15A patent/RU2006101225A/ru not_active Application Discontinuation
- 2004-06-10 AU AU2004249151A patent/AU2004249151A1/en not_active Abandoned
- 2004-06-15 US US10/869,169 patent/US20040254251A1/en not_active Abandoned
- 2004-06-16 TW TW093117335A patent/TW200524639A/zh unknown
-
2005
- 2005-11-17 ZA ZA200509379A patent/ZA200509379B/xx unknown
- 2005-11-28 IL IL172233A patent/IL172233A0/en unknown
- 2005-12-12 NO NO20055880A patent/NO20055880L/no not_active Application Discontinuation
-
2006
- 2006-07-13 US US11/457,182 patent/US20060251717A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200509379B (en) | 2006-11-29 |
| CA2529535A1 (en) | 2004-12-29 |
| WO2004112768A1 (en) | 2004-12-29 |
| JP2006527774A (ja) | 2006-12-07 |
| US20040254251A1 (en) | 2004-12-16 |
| AU2004249151A1 (en) | 2004-12-29 |
| EP1631273A1 (en) | 2006-03-08 |
| MXPA05012810A (es) | 2006-02-13 |
| RU2006101225A (ru) | 2006-06-10 |
| TW200524639A (en) | 2005-08-01 |
| NO20055880L (no) | 2005-12-28 |
| IL172233A0 (en) | 2006-04-10 |
| PL378902A1 (pl) | 2006-05-29 |
| CN1805737A (zh) | 2006-07-19 |
| KR20060033727A (ko) | 2006-04-19 |
| US20060251717A1 (en) | 2006-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0411451A (pt) | formas de dosagens orais de memantina | |
| CY1116041T1 (el) | Μεσα και μεθοδοι για τη θεραπευτικη αγωγη νεοπλασματικων νοσων | |
| Mercadante et al. | Pharmacological management of cancer pain in the elderly | |
| BRPI0513200A (pt) | uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas | |
| BR0015974A (pt) | Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto | |
| CY1119001T1 (el) | Ενωσεις 1,2,4-οξαδιαζολο βενζοϊκου οξεος και χρηση αυτων για ανευ νοηματος καταστολη και τη θεραπεια ασθενειας | |
| BRPI0511296A (pt) | sensibilização à outra terapia anticáncer e/ou melhora de um efeito colateral de outra terapia anticáncer por tratamento com um composto anticáncer ativado por gst | |
| BRPI0507966A (pt) | uso de meloxicam para o tratamento de doenças respiratórias em porcos | |
| BR0316906A (pt) | administração do capsaicinoides | |
| ATE543491T1 (de) | Kombinationspräparat enthaltend ibuprofen und paracetamol | |
| BRPI0510895A (pt) | formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t | |
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| BRPI0313424B8 (pt) | forma de dosagem e processo para a preparação de uma forma de dosagem | |
| AR045972A1 (es) | Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas | |
| KR960700054A (ko) | 파킨슨씨 병 및 파킨슨 증후군의 치료에 리루졸의 이용(application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes) | |
| BRPI0406883A (pt) | Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto | |
| CY1106430T1 (el) | Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο | |
| BR0115162A (pt) | Tratamentos antitumorais eficazes | |
| BRPI0411079A (pt) | composições farmacêuticas compreendendo atorvastatina, fabricadas sem granulação | |
| BR0009380A (pt) | Tratamento de câncer melhorado comtemozolomida | |
| RU2003127718A (ru) | Применение флумазенила в производстве лекарственного средства для лечения кокаиновой зависимости | |
| BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
| KR960028907A (ko) | 암환자를 치료하기 위한 세트랄린의 용도 | |
| HUP0401798A2 (hu) | Rosuvastatin alkalmazása demencia előtti állapotokban használható gyógyszerkészítmény előállítására | |
| MX2010006310A (es) | O-desmetil-venlafaxina para el tratamiento de transtorno depresivo mayor. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A , 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. |